323 related articles for article (PubMed ID: 27903960)
1. Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study.
Wu L; Fu J; Wan L; Pan J; Lai S; Zhong J; Chung DC; Wang L
Oncotarget; 2017 Jan; 8(3):4935-4947. PubMed ID: 27903960
[TBL] [Abstract][Full Text] [Related]
2. The Lymph Node Ratio Optimizes Staging in Patients with Small Intestinal Neuroendocrine Tumors.
Wu L; Chen F; Chen S; Wang L
Neuroendocrinology; 2018; 107(3):209-217. PubMed ID: 29920478
[TBL] [Abstract][Full Text] [Related]
3. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
Zheng M; Li Y; Li T; Zhang L; Zhou L
Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
Fang C; Wang W; Zhang Y; Feng X; Sun J; Zeng Y; Chen Y; Li Y; Chen M; Zhou Z; Chen J
Chin J Cancer; 2017 Jun; 36(1):51. PubMed ID: 28637502
[TBL] [Abstract][Full Text] [Related]
5. Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis.
Guller U; Tarantino I; Cerny T; Ulrich A; Schmied BM; Warschkow R
Gastric Cancer; 2017 Jan; 20(1):49-60. PubMed ID: 26649434
[TBL] [Abstract][Full Text] [Related]
6. Duodenal localization is a negative predictor of survival after small bowel adenocarcinoma resection: A population-based, propensity score-matched analysis.
Wilhelm A; Galata C; Beutner U; Schmied BM; Warschkow R; Steffen T; Brunner W; Post S; Marti L
J Surg Oncol; 2018 Mar; 117(3):397-408. PubMed ID: 29044591
[TBL] [Abstract][Full Text] [Related]
7. Effect of primary tumour resection without curative intent in patients with metastatic neuroendocrine tumours of the small intestine and right colon: meta-analysis.
Van Den Heede K; Chidambaram S; Van Slycke S; Brusselaers N; Warfvinge CF; Ohlsson H; Nordenström E; Almquist M
Br J Surg; 2022 Feb; 109(2):191-199. PubMed ID: 34941998
[TBL] [Abstract][Full Text] [Related]
8. A nomogram to assess small-intestinal neuroendocrine tumor ('carcinoid') survival.
Modlin IM; Gustafsson BI; Pavel M; Svejda B; Lawrence B; Kidd M
Neuroendocrinology; 2010; 92(3):143-57. PubMed ID: 20733279
[TBL] [Abstract][Full Text] [Related]
9. Surgical Management of Adolescents and Young Adults With Gastrointestinal Stromal Tumors: A US Population-Based Analysis.
Fero KE; Coe TM; Fanta PT; Tang CM; Murphy JD; Sicklick JK
JAMA Surg; 2017 May; 152(5):443-451. PubMed ID: 28114506
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Factors Associated with Outcomes in Small Bowel Neuroendocrine Tumors.
Manguso N; Johnson J; Harit A; Nissen N; Mirocha J; Hendifar A; Amersi F
Am Surg; 2017 Oct; 83(10):1174-1178. PubMed ID: 29391119
[TBL] [Abstract][Full Text] [Related]
11. Surgical Treatment of Small Bowel Neuroendocrine Tumors.
Farley HA; Pommier RF
Hematol Oncol Clin North Am; 2016 Feb; 30(1):49-61. PubMed ID: 26614368
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological features and multivariate analysis of prognostic factors for patients with gastroenteropancreatic neuroendocrine tumors].
Wang X; Song ZF; Yao WX; Pan CC; Xiang MF; Wang H
Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1411-4. PubMed ID: 24025507
[TBL] [Abstract][Full Text] [Related]
13. Comparable survival benefit of local excision versus radical resection for 10- to 20-mm rectal neuroendocrine tumors.
Chen Q; Chen J; Huang Z; Zhao H; Cai J
Eur J Surg Oncol; 2022 Apr; 48(4):864-872. PubMed ID: 34753616
[TBL] [Abstract][Full Text] [Related]
14. Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.
Pasquer A; Walter T; Hervieu V; Forestier J; Scoazec JY; Lombard-Bohas C; Poncet G
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S742-9. PubMed ID: 26014153
[TBL] [Abstract][Full Text] [Related]
15. Mesenteric Lymphadenectomy in Well-Differentiated Appendiceal Neuroendocrine Tumors.
Raoof M; Dumitra S; O'Leary MP; Singh G; Fong Y; Lee B
Dis Colon Rectum; 2017 Jul; 60(7):674-681. PubMed ID: 28594716
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological Characteristics and Survival Outcomes of Primary Hepatic Neuroendocrine Tumor: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Study.
Li YF; Zhang QQ; Wang WL
Med Sci Monit; 2020 Jul; 26():e923375. PubMed ID: 32651994
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic features, surgical treatments, and outcomes of small bowel tumors: A retrospective study in China.
Zhang S; Zheng C; Chen Y; Xu Q; Ma J; Yuan W; Jiang Q; Zhao Y; Zhang J; Che X; Wang C; Huang X; Chen F; Wang N; Ma X; Lan Z
Int J Surg; 2017 Jul; 43():145-154. PubMed ID: 28583893
[TBL] [Abstract][Full Text] [Related]
18. The Number of Lymph Nodes Examined is Associated with Survival Outcomes of Neuroendocrine Tumors of the Jejunum and Ileum (siNET): Development and Validation of a Prognostic Model Based on SEER Database.
Wang P; Chen E; Xie M; Xu W; Ou C; Zhou Z; Niu Y; Song W; Ni Q; Zhu J
J Gastrointest Surg; 2022 Sep; 26(9):1917-1929. PubMed ID: 35689008
[TBL] [Abstract][Full Text] [Related]
19. Toward a Preoperative Classification of Lymph Node Metastases in Patients with Small Intestinal Neuroendocrine Tumors in the Era of Intestinal-Sparing Surgery.
Lardière-Deguelte S; de Mestier L; Appéré F; Vullierme MP; Zappa M; Hoeffel C; Noaves M; Brixi H; Hentic O; Ruszniewski P; Cadiot G; Panis Y; Kianmanesh R
Neuroendocrinology; 2016; 103(5):552-9. PubMed ID: 26445315
[TBL] [Abstract][Full Text] [Related]
20. Metastasis Prevalence and Survival of Patients with T1-2 Gastric Neuroendocrine Tumor Treated with Endoscopic Therapy and Surgery.
Wang M; Cheng S; Zhu L; Xu T; Zhang J; Zhang Y; Ping J; Wang R
Dig Dis Sci; 2022 Jul; 67(7):3228-3238. PubMed ID: 34272627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
